News|Articles|April 2, 2004
- Pharmaceutical Technology-04-02-2004
- Volume 28
- Issue 4
Controlled-Release Dosage Forms for Diltiazem Hydrochloride
Author(s)Ramesh Panchagnula, PhD
The authors investigate whether an extrusion-spheronization proces can be used to develop a matrix-based, controlled-release formulation for a highly water-soluble drug.
Advertisement
Articles in this issue
over 21 years ago
Spotlight on Business Riskover 21 years ago
Vibration Technology for Active Dry-Powder Inhalersover 21 years ago
In the Spotlight April 2004over 21 years ago
FDA Attacks Counterfeitsover 21 years ago
Synthetic Excipients Challenge All-Natural Organicsover 21 years ago
April 2004Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
